Hester Biosciences Ltd.
| BSE: 524669 | Sector: Health care |
| NSE: HESTERBIO | ISIN Code: INE782E01017 |
| BSE 00:00 | 31 Jan | 1868.50 |
92.45 (5.21%) |
OPEN
1774.70 |
HIGH
1922.20 |
LOW
1701.00 |
| NSE 00:00 | 31 Jan | 1867.80 |
101.60 (5.75%) |
OPEN
1775.00 |
HIGH
1925.00 |
LOW
1670.00 |
| OPEN | 1774.70 |
| PREVIOUS CLOSE | 1776.05 |
| VOLUME | 1086 |
| 52-Week high | 2851.75 |
| 52-Week low | 1701.00 |
| P/E | 51.52 |
| Mkt Cap.(Rs cr) | 1,590 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Hester Biosciences Ltd. (HESTERBIO) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Cipla | 1017.00 | -17.80 | -1.72 | 2957.93 |
| Divi's Lab. | 3317.45 | -49.90 | -1.48 | 2948.54 |
| Glenmark Pharma. | 384.25 | 13.15 | 3.54 | 1997.79 |
| Glaxosmi. Pharma | 1246.70 | -11.95 | -0.95 | 1690.53 |
| Dr Reddy's Labs | 4324.00 | -7.45 | -0.17 | 1623.20 |
| Alkem Lab | 3009.75 | 2.35 | 0.08 | 1541.25 |
| Aurobindo Pharma | 408.30 | -3.30 | -0.80 | 1454.71 |
| Gland Pharma | 1300.20 | -9.75 | -0.74 | 1212.16 |
| Torrent Pharma. | 1521.45 | -26.20 | -1.69 | 991.45 |
| Sanofi India | 5495.95 | -28.35 | -0.51 | 944.40 |
| Ipca Labs. | 850.15 | -5.20 | -0.61 | 870.94 |
| Zydus Lifesci. | 430.75 | 2.85 | 0.67 | 857.90 |
| Abbott India | 20842.40 | -125.35 | -0.60 | 798.70 |
| Laurus Labs | 330.40 | -11.45 | -3.35 | 750.09 |
| Ajanta Pharma | 1208.40 | 0.50 | 0.04 | 719.86 |
| Apollo Hospitals | 4255.55 | 17.25 | 0.41 | 665.20 |
| Pfizer | 3871.85 | -76.85 | -1.95 | 612.56 |
| Suven Pharma | 492.50 | 4.15 | 0.85 | 558.10 |
| Alembic Pharma | 538.10 | 0.80 | 0.15 | 543.55 |
| Glenmark Life | 386.65 | 0.65 | 0.17 | 418.72 |
Quick Links for Hester Biosciences:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
